At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 10, 2026 at 17:49 ET
Intracoastal Capital LLC and its principals filed an amended Schedule 13G disclosing a 9.99% passive stake in Sunshine Biopharma, consisting of 430,336 shares issuable upon exercise of a warrant. The stake is unchanged from the prior filing, and the filing certifies no intent to influence control.
- Intracoastal Capital LLC and its principals Mitchell P. Kopin and Daniel B. Asher filed an amended Schedule 13G.
- The filing reports beneficial ownership of 430,336 shares of common stock issuable upon exercise of a warrant.
- The stake represents approximately 9.99% of the outstanding common stock based on 3,877,337 shares outstanding plus the 430,336 warrant shares.
- The warrant contains a blocker provision preventing exercise above 9.99% beneficial ownership.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access